포항공과대학교 총장 김용민 박사 특강 안내

우리대학 총장이신 김용민 박사님을 초청하여 특별강연을 갖고자 하오니 대학 구성원 여러분의

많은 참석을 바랍니다.

■ 제 목 : NEW 21ST CENTURY RELATIONSHIP BETWEEN ACADEMIA AND INDUSTRY

■ 일 시 : 2012. 3. 30(금) 14:00 ~ 15:30

■ 장 소 : LG연구동 강당

■ 참석대상 : 대학 전 구성원

■ 주관 : 전자전기공학과, BK21 미래정보기술사업단

■ 문의사항 : BK21 미래정보기술사업단 최주애 (T.279-8116)

2012. 3. 27

BK21 미래정보기술사업단장

Special Lecture by President Yongmin Kim

We are pleased to announce a special lecture by President Yongmin Kim as follows.

■ Title: NEW 21ST CENTURY RELATIONSHIP BETWEEN ACADEMIA AND INDUSTRY

■ Date & Time: Friday, March 30, 2012 (2:00 – 3:30 p.m.)

■ Venue: LG Cooperative Electronics Engineering Bldg (Auditorium)

■ All POSTECH members are welcome to attend.

■ Hosted by: Dept. of Electrical Engineering & BK21 Educational Institute of Future Information Technology

■ For inquiries, please contact Miss. Choi, Joo Ae at 279-8116.

*This lecture will be delivered in English.

March 27, 2012

BK21 Educational Institute of Future Information Technology

NEW 21^ST CENTURY RELATIONSHIP BETWEEN ACADEMIA AND INDUSTRY

Yongmin Kim, Ph.D.

President of POSTECH

Pohang, Gyeongbuk

KOREA

World-class research-oriented universities play a key role in making remarkable discoveries and developing breakthrough technologies. These discoveries and new technologies need to be translated towards practical use.  Unfortunately, the gap between academia and industry has been deepening and widening, which poses a great dilemma even to leading universities in the U.S.

There are several grand challenges in the 21^st century, e.g., energy, environment, food and global health.  In healthcare, new biomedical technologies, ranging from diagnostic and therapeutic devices to bioinformatics and biotechnology, could transform and revolutionize future medicine and healthcare.  Although many pioneering discoveries are being made and new exciting technologies are being developed in academia and research institutes, even the most promising technologies face numerous obstacles in technology commercialization and eventual routine clinical use.  They typically languish and die in the valley of death, frustrating the researchers and angel investors/venture capitalists alike. 

Translational research from lab bench to the marketplace where products and services are provided and consumed is far more difficult and time-consuming than many people estimate or are willing to tolerate.  In spite of this difficulty, academia and industry need to strive to work together with trust and patience and develop a mutually-beneficial relationship.  In this presentation, I will share my experience and observations on the obstacles and formula of success (or failure) in translational research and technology commercialization in science and engineering with several entrepreneurship and technology commercialization examples.